There are currently no available treatment options for any form of frontotemporal dementia that have been approved by the EMA ...
The US company CervoMed announced yesterday that the FDA has granted Orphan Drug Designation to its oral investigational ...
Parkinson’s disease is a brain disorder that affects about one million people in the U.S. It happens when the brain loses ...
Someone with FTD may also notice changes in personality or mood and difficulties with language. Dr. McGrath points out that ...
CervoMed (CRVO) stock rises as FDA grants Orphan Drug Designation for neflamapimod to treat frontotemporal dementia. Read ...
Designation underscores significant unmet need in frontotemporal dementia and the potential role of neflamapimod in multiple neurologic disorders. On track to report topline data ...
The company is on track to report topline data from the RewinD-LB Phase 2b clinical trial in early-stage dementia with Lewy bodies (DLB) in December 2024. The company is continuing to prepare to ...
Behold the Body. Electron microgram of a Biondi body shows a dense core surrounded by filaments that bind gold-labeled secondary antibody to TMEM239 (black dots). [Courtesy of Ghetti et al., 2024.] ...
Investigators led by Tanya Simuni, MD, the Arthur C. Nielsen, Jr., Research Professor of Parkinson's Disease and Movement ...
Dementia charity Lewy Body Society is celebrating its five years of funding the UK’s first Consultant Admiral Nurse for Lewy ...
Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, announces a groundbreaking paper in The Lancet Neurology. The study demonstrates the ...
Model mice treated with extracts and powders exhibit restored cognitive and motor functions. Efforts to develop a ...